Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1212

Similar articles for PubMed (Select 17968166)

1.

Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.

Kim JC, Takahashi K, Yu CS, Kim HC, Kim TW, Ryu MH, Kim JH, Mori T.

Ann Surg. 2007 Nov;246(5):754-62.

PMID:
17968166
2.

Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?

Hughes R, Glynne-Jones R, Grainger J, Richman P, Makris A, Harrison M, Ashford R, Harrison RA, Livingstone JI, McDonald PJ, Meyrick Thomas J, Mitchell IC, Northover JM, Phillips R, Wallace M, Windsor A, Novell JR.

Int J Colorectal Dis. 2006 Jan;21(1):11-7. Epub 2005 Apr 30.

PMID:
15864605
3.

Lateral pelvic lymph node dissection for advanced lower rectal cancer.

Fujita S, Yamamoto S, Akasu T, Moriya Y.

Br J Surg. 2003 Dec;90(12):1580-5.

PMID:
14648739
4.

Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.

Akiyoshi T, Ueno M, Matsueda K, Konishi T, Fujimoto Y, Nagayama S, Fukunaga Y, Unno T, Kano A, Kuroyanagi H, Oya M, Yamaguchi T, Watanabe T, Muto T.

Ann Surg Oncol. 2014 Jan;21(1):189-96. doi: 10.1245/s10434-013-3216-y. Epub 2013 Aug 21.

PMID:
23963871
5.

Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.

Laurent C, Nobili S, Rullier A, Vendrely V, Saric J, Rullier E.

J Am Coll Surg. 2006 Nov;203(5):684-91. Epub 2006 Sep 20.

PMID:
17084330
6.

Prognostic significance of circumferential resection margin following total mesorectal excision and adjuvant chemoradiotherapy in patients with rectal cancer.

Baik SH, Kim NK, Lee YC, Kim H, Lee KY, Sohn SK, Cho CH.

Ann Surg Oncol. 2007 Feb;14(2):462-9. Epub 2006 Nov 10.

PMID:
17096053
7.

Preoperative radio-chemotherapy (RT-CT) in rectal cancer. Prospective study with postoperative RT-CT control group.

Cambray i Amenós M, Navarro García M, Martí Ragué J, Pareja Fernández L, Pera Fábregas J.

Clin Transl Oncol. 2007 Mar;9(3):183-91.

PMID:
17403630
8.

Impact of neoadjuvant treatment on total mesorectal excision for ultra-low rectal cancers.

Lim YK, Law WL, Liu R, Poon JT, Fan JF, Lo OS.

World J Surg Oncol. 2010 Mar 26;8:23. doi: 10.1186/1477-7819-8-23.

9.

Lymph node micrometastasis in stage II distal rectal cancer following neoadjuvant chemoradiation therapy.

Perez RO, Habr-Gama A, Nishida Arazawa ST, Rawet V, Coelho Siqueira SA, Kiss DR, Gama-Rodrigues JJ.

Int J Colorectal Dis. 2005 Sep;20(5):434-9. Epub 2005 Mar 10.

PMID:
15759124
10.

Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.

Bonnen M, Crane C, Vauthey JN, Skibber J, Delclos ME, Rodriguez-Bigas M, Hoff PM, Lin E, Eng C, Wong A, Janjan NA, Feig BW.

Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1098-105.

PMID:
15519780
11.

Stage-to-stage comparison of preoperative and postoperative chemoradiotherapy for T3 mid or distal rectal cancer.

Yeo SG, Kim DY, Park JW, Choi HS, Oh JH, Kim SY, Chang HJ, Kim TH, Sohn DK.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):856-62. doi: 10.1016/j.ijrobp.2010.10.079. Epub 2011 Feb 6.

PMID:
21300482
12.

Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.

Liersch T, Langer C, Ghadimi BM, Kulle B, Aust DE, Baretton GB, Schwabe W, Häusler P, Becker H, Jakob C.

J Clin Oncol. 2006 Sep 1;24(25):4062-8.

13.

Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.

Tural D, Ozturk M, Selcukbiricik F, Yildiz O, Elicin O, Turna H, Guney S, Ozguroglu M.

J BUON. 2013 Apr-Jun;18(2):385-90.

PMID:
23818350
14.

Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.

Lim SB, Choi HS, Jeong SY, Kim DY, Jung KH, Hong YS, Chang HJ, Park JG.

Ann Surg. 2008 Aug;248(2):243-51. doi: 10.1097/SLA.0b013e31817fc2a0.

PMID:
18650634
15.

The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.

Lindebjerg J, Spindler KL, Ploen J, Jakobsen A.

Colorectal Dis. 2009 Mar;11(3):264-9. doi: 10.1111/j.1463-1318.2008.01599.x. Epub 2008 Jun 20.

PMID:
18573119
16.

Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.

Chan AK, Wong A, Jenken D, Heine J, Buie D, Johnson D.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):665-77.

PMID:
15708244
17.

Safety of laparoscopic total mesorectal excision for low rectal cancer with preoperative chemoradiation therapy.

Akiyoshi T, Kuroyanagi H, Oya M, Konishi T, Fukuda M, Fujimoto Y, Ueno M, Yamaguchi T, Muto T.

J Gastrointest Surg. 2009 Mar;13(3):521-5. doi: 10.1007/s11605-008-0744-z. Epub 2008 Nov 15.

PMID:
19011946
18.

Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.

Peng J, Lu JJ, Zhu J, Xu Y, Lu H, Lian P, Cai G, Cai S.

Cancer J. 2008 Jan-Feb;14(1):54-61. doi: 10.1097/PPO.0b013e3181629a67.

PMID:
18303484
20.

Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection.

Kobayashi H, Mochizuki H, Kato T, Mori T, Kameoka S, Shirouzu K, Sugihara K.

Dis Colon Rectum. 2009 Apr;52(4):567-76. doi: 10.1007/DCR.0b013e3181a1d994.

PMID:
19404054
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk